Form 4: Bio-Key International CEO Acquires Shares

Michael DePasquale, CEO of Bio-Key International, acquired 250 shares of common stock through an employee stock purchase plan.

Summary

• Michael DePasquale, Chief Executive Officer and Chairman of Bio-Key International, Inc., acquired 250 shares of common stock.
• The acquisition occurred on June 30, 2026, at a price of $3.83 per share.
• These shares were acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan, as amended.
• The transaction is exempt under Rule 16b-3(d) and Rule 16b-3(c).
• Following the transaction, DePasquale beneficially owns 10,778 shares of common stock.
• All share amounts reflect Bio-Key's 1-for-10 reverse stock split, effective April 30, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine insider stock acquisition under an employee plan, without providing new financial or strategic information.

Positives

• CEO's acquisition of company stock can signal confidence in the company's future prospects.
• Acquisition made through an employee stock purchase plan, suggesting participation in long-term equity growth.
• The transaction is structured to be exempt from certain reporting requirements, indicating adherence to regulatory frameworks.

Future Outlook

No specific forward-looking statements or guidance are provided in this filing, which is a statement of changes in beneficial ownership.

Industry Context

StockSavvy.ai notes that insider transactions, such as this stock acquisition by Bio-Key International's CEO, are closely watched by investors as potential indicators of management's confidence in the company's valuation and future performance within the cybersecurity and identity verification sector.

Stakeholder Impact

• Shareholders: The acquisition by the CEO may be interpreted as a positive signal of confidence, potentially influencing investor sentiment.
• Employees: Participation in the stock purchase plan allows employees to invest in the company's equity.
• Management: The transaction reflects the CEO's continued investment in the company.

Key Dates

Keywords

Bio-Key International, BKYI, Form 4, Insider Trading, Stock Purchase Plan, Michael DePasquale, SEC Filing, Common Stock